Latest filing published 17 Jul 2026 for MapLight Therapeutics, Inc., €601k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jonathan Gillis: trading record in brief
Jonathan Gillis appears in our data through filings on MapLight Therapeutics, Inc. shares, published by SEC (Form 4). Between 15 July 2026 and 17 July 2026, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 17 July 2026: a transaction of €601k, in MapLight Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jonathan Gillis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 18,469 shares@ US$37.22CommonSEC144:0001950047-26-007188
- 36,979 shares@ US$37.910.082% mcap100.0% of flowMapLight voting common stockSEC144:0001193125-26-305149
2 of 2 declarations